| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |